The Impacts of National Centralized Drug Procurement Policy on Drug Utilization and Drug Expenditures: The Case of Shenzhen, China

In 2019, the Chinese government implemented the first round of the National Centralized Drug Procurement (NCDP) pilot (so-called “4 + 7” policy) in mainland China, in which 25 drugs were included. We conducted this study to examine the impacts of NCDP policy on drug utilization and expenditures, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lei, Yang, Ying, Luo, Mi, Hu, Borui, Yin, Shicheng, Mao, Zongfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765443/
https://www.ncbi.nlm.nih.gov/pubmed/33334027
http://dx.doi.org/10.3390/ijerph17249415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765443/
https://www.ncbi.nlm.nih.gov/pubmed/33334027
http://dx.doi.org/10.3390/ijerph17249415

Ejemplares similares